La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Ali Samii And NotMaryland

List of bibliographic references

Number of relevant bibliographic references: 12.
Ident.Authors (with country if any)Title
000F97 Siavash Jafari [Canada] ; Mahyar Etminan [Canada] ; Farhad Aminzadeh [Royaume-Uni] ; Ali Samii [États-Unis]Head injury and risk of Parkinson disease: A systematic review and meta‐analysis
002077 Ali Samii [États-Unis] ; Mahyar Etminan [Canada] ; Matthew O. Wiens [Canada] ; Siavash Jafari [Canada]NSAID Use and the Risk of Parkinson's Disease: Systematic Review and Meta-Analysis of Observational Studies
002165 Mahyar Etminan [Canada] ; Bruce C. Carleton ; Ali SamiiNon-steroidal anti-inflammatory drug use and the risk of Parkinson disease: a retrospective cohort study.
002978 Mahyar Etminan [Canada] ; Sudeep S. Gill ; Ali SamiiIntake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: a meta-analysis.
002C24 Mahyar Etminan [Canada] ; Bahi Takkouche [Espagne] ; Francisco Caama O Isorna [Espagne] ; Ali Samii [États-Unis]Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies
002E67 Mahyar Etminan [Canada] ; Sudeep Gill [Canada] ; Ali Samii [États-Unis]Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies
002F45 Mahyar Etminan [Canada] ; Sudeep Gill [Canada] ; Ali Samii [États-Unis]Comparison of the risk of adverse events with Pramipexole and ropinirole in patients with Parkinson's disease a meta-analysis
002F94 Pramod K. Pal [Canada] ; Joanne Leung [États-Unis] ; Katya Hedrich [Allemagne] ; Ali Samii [Canada] ; Abraham Lieberman [États-Unis] ; Paul A. Nausieda [États-Unis] ; Donald B. Calne [Canada] ; Xandra O. Breakefield [États-Unis] ; Christine Klein [Allemagne] ; A. Jon Stoessl [Canada][18F]‐Dopa positron emission tomography imaging in early‐stage, non‐parkin juvenile parkinsonism
003310 Mahyar Etminan [Canada] ; Ali Samii [États-Unis] ; Bahi Takkouche [Espagne] ; Paula A. Rochon [Canada]Increased risk of somnolence with the new dopamine agonists in Patients with Parkinson's disease: A meta-analysis of randomised controlled trials
003485 Chong S. Lee [Canada] ; Ali Samii [Canada] ; Vesna Sossi [Canada] ; Thomas J. Ruth [Canada] ; Michael Schulzer [Canada] ; James E. Holden [États-Unis] ; Jess Wudel [Canada] ; Pramod K. Pal [Canada] ; Raul De La Fuente-Fernandez [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada]In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease
003786 P. K Pal [Canada] ; S. Calne [Canada] ; Ali Samii [Canada] ; J. A. E Fleming [Canada]A review of normal sleep and its disturbances in Parkinson’s disease
003946 Ali Samii [Canada] ; Shallen R. Letwin [Canada] ; Donald B. Calne [Canada]Prospects for new drug treatment in idiopathic parkinsonism

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022